Skip to main content
. 2014 Aug 25;5(4):155–165. doi: 10.14740/wjon855w

Table 4. Dose-Modifying Factors for Quiescent Cells Relative to the Total Tumor Cell Populationa.

Without thalidomide With thalidomide (once) With thalidomide (twice)
Net micronucleus frequency = 0.6
  γ-Rays only 1.65 ± 0.15b 1.6 ± 0.1 1.9 ± 0.15
  With nicotinamide 1.8 ± 0.15 2.0 ± 0.15 1.8 ± 0.15
  With mild temperature hyperthermia 1.6 ± 0.15 1.55 ± 0.1 1.7 ± 0.1

aThe ratio of the dose of radiation necessary to obtain each end-point in the quiescent cell population to that needed to obtain each end-point in the total tumor cell population. bMean ± standard error (n = 6).